Control group:Patients will receive standard lifestyle intervention
Sponsors
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Department of Infectious Disease, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, China(The People's Hospital of Nanhai, Foshan)
Conditions
Metabolic-Associated Fatty Liver DiseaseNon-alcoholic fatty liver disease
Unknown Phase
Application of lifestyle intervention-based digital therapeutics in Patients with non-alcoholic fatty liver disease
Active, not recruitingChiCTR2500100197
Start: 2022-08-17Updated: 2025-04-07
Efficacy of Digital Therapeutics Based on Mobile Internet Technology in Patients with Metabolic-Associated Fatty Liver Disease
Active, not recruitingChiCTR2500108822
Start: 2023-01-03Updated: 2025-09-08